Caldwell Sutter Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.8K Buy
300
+25
+9% +$188 ﹤0.01% 767
2025
Q4
$1.97K Sell
275
-25
-8% -$198 ﹤0.01% 748
2025
Q3
$3.2K Sell
300
-159
-35% -$1.56K ﹤0.01% 688
2025
Q2
$4.44K Sell
459
-512
-53% -$5.28K ﹤0.01% 629
2025
Q1
$14.5K Hold
971
0.01% 504
2024
Q4
$14.5K Buy
971
+434
+81% +$7.07K 0.01% 514
2024
Q3
$10.3K Sell
537
-8
-1% -$166 ﹤0.01% 551
2024
Q2
$11.3K Sell
545
-9
-2% -$179 0.01% 544
2024
Q1
$10.4K Buy
554
+144
+35% +$2.47K 0.01% 542
2023
Q4
$5.91K Buy
410
+5
+1% +$68 ﹤0.01% 604
2023
Q3
$7.03K Sell
405
-341
-46% -$7.11K ﹤0.01% 563
2023
Q2
$15.5K Buy
746
+275
+58% +$5.98K 0.01% 479
2023
Q1
$11.1K Buy
471
+324
+220% +$8.7K 0.01% 385
2022
Q4
$4.11K Buy
+147
New +$3.76K ﹤0.01% 286

Other funds holding OGN

Caldwell Sutter Capital's OGN Position: Q1 2026 in Review

Caldwell Sutter Capital increased its Organon & Co (OGN) stake by 9.1% in Q1 2026, buying an estimated $188 and bringing the position to 300 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Caldwell Sutter Capital first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $15.5K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Caldwell Sutter Capital held 300 shares of Organon & Co worth $1.8K as of Q1 2026.
  • Caldwell Sutter Capital bought 25 Organon & Co shares in Q1 2026, an estimated $188.
  • Organon & Co made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #767 holding.
  • Caldwell Sutter Capital first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Caldwell Sutter Capital's Organon & Co position peaked at $15.5K in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.